Published in Cancer Med on April 27, 2015
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2007) 25.52
High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci U S A (2004) 3.75
The mechanism of spindle assembly: functions of Ran and its target TPX2. J Cell Biol (2004) 2.58
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer (2000) 2.08
Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res (1997) 1.74
Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am (1998) 1.74
Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer (1999) 1.72
Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol (2005) 1.56
Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res (2010) 1.47
Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Clin Cancer Res (2009) 1.29
Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. Cancer Res (2007) 1.28
Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene (2006) 1.22
TPX2: of spindle assembly, DNA damage response, and cancer. Cell Mol Life Sci (2014) 1.15
Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Clin Cancer Res (2006) 1.09
Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol (2002) 1.08
TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer. J Transl Med (2013) 1.07
Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci (2002) 1.06
The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer. Oncol Rep (2012) 1.05
Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition. Mol Cancer Ther (2006) 1.01
Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma. Tumour Biol (2013) 0.96
Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events. Blood (2011) 0.96
Targeting protein for xenopus kinesin-like protein 2 (TPX2) regulates γ-histone 2AX (γ-H2AX) levels upon ionizing radiation. J Biol Chem (2012) 0.93
Anti-tumor efficacy of paclitaxel against human lung cancer xenografts. Jpn J Cancer Res (1997) 0.90
Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts. Int J Cancer (2008) 0.87
TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma. J Gastroenterol (2013) 0.87
Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma. Biomed Res Int (2014) 0.84
Growth factors in pancreatic health and disease. Pancreatology (2001) 0.83
Methods and timing of biliary drainage for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.19
Advances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategies. Surg Today (2009) 1.03
The Predictive Value of Indocyanine Green Clearance in Future Liver Remnant for Posthepatectomy Liver Failure Following Hepatectomy with Extrahepatic Bile Duct Resection. World J Surg (2016) 0.87
Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method. Gastric Cancer (2014) 0.79
Muscle sparing thoracotomy for esophageal cancer: a comparison with posterolateral thoracotomy. Surg Today (2015) 0.77
A Clear Difference Between the Outcomes After a Major Hepatectomy With and Without an Extrahepatic Bile Duct Resection. World J Surg (2016) 0.77
Surgery-Related Muscle Loss and Its Association with Postoperative Complications After Major Hepatectomy with Extrahepatic Bile Duct Resection. World J Surg (2016) 0.76
Clinical value and pitfalls of fluorescent cholangiography during single-incision laparoscopic cholecystectomy. Surg Today (2016) 0.76
The feasibility of laparoscopic extended pelvic surgery for rectal cancer. Surg Today (2015) 0.76
Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol (2015) 0.76
Surgical and Radiological Studies on the Length of the Hepatic Ducts. World J Surg (2015) 0.76
Successful bypass operation for esophageal obstruction after acute esophageal necrosis: a case report. Surg Case Rep (2017) 0.75
Gradually shrinking intra-abdominal desmoid tumor derived from the stomach in a young boy: a case report. Surg Case Rep (2017) 0.75
Occult mucin-producing cholangiocarcinoma in situ: a rare clinical case with difficult tumour staging. Surg Case Rep (2017) 0.75
Role of extended surgery for pancreatic cancer: critical review of the four major RCTs comparing standard and extended surgery. J Hepatobiliary Pancreat Sci (2011) 0.75
Percutaneous transhepatic portal vein stenting for malignant portal vein stenosis secondary to recurrent perihilar biliary cancer. J Hepatobiliary Pancreat Sci (2015) 0.75
Six-year survival following left hepatic trisectionectomy with simultaneous resection of the portal vein and right hepatic artery for advanced perihilar cholangiocarcinoma without lymph node metastases: report of a case. Clin J Gastroenterol (2012) 0.75
Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report. Surg Case Rep (2017) 0.75
Study of the Portal Branches Arising from the Cranial Part of the Umbilical Portion of the Left Portal Vein: Implications for Anatomic Right Hepatic Trisectionectomy. World J Surg (2020) 0.75
Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor. Surg Case Rep (2017) 0.75
Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis. Surg Today (2016) 0.75
Uneven acute non-alcoholic fatty change of the liver after percutaneous transhepatic portal vein embolization in a patient with hilar cholangiocarcinoma - a case report. BMC Gastroenterol (2017) 0.75
Role of bevacizumab in neoadjuvant chemotherapy and its influence on microvessel density in rectal cancer. Int J Clin Oncol (2015) 0.75
The effects of bevacizumab on intestinal anastomotic healing in rabbits. Surg Today (2016) 0.75
The development of an automatically produced cholangiography procedure using the reconstruction of portal-phase multidetector-row computed tomography images: preliminary experience. Surg Today (2016) 0.75
Retrosternal Reconstruction Can be a Risk Factor for Upper Extremity Deep Vein Thrombosis After Esophagectomy. World J Surg (2017) 0.75
Clinical value of a prophylactic minitracheostomy after esophagectomy: analysis in patients at high risk for postoperative pulmonary complications. BMC Surg (2017) 0.75
Tracheoesophageal fistula after total resection of gastric conduit for gastro-aortic fistula due to gastric ulcer. Surg Case Rep (2017) 0.75